This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Zhang, Y. Articles by Sonner, J. M. Search for Related Content PubMed PubMed Citation Articles by Zhang, Y. Articles by Sonner, J. M. Related Collections Pharmacology

---

ANESTHETIC PHARMACOLOGY

Blockade of 5-HT2A Receptors May Mediate or Modulate Part of the Immobility Produced by Inhaled Anesthetics

Department of Anesthesia and Perioperative Care, University of California, San Francisco, California

Address correspondence and reprint requests to Dr. James M. Sonner, Department of Anesthesia, S-455i, Box 0464, University of California, San Francisco, CA 94143-0464. Address e-mail to sonnerj{at}anesthesia.ucsf.edu

Many inhaled anesthetics block the in vitro effect of the excitatory neurotransmitter serotonin on the 5-HT2A receptor, supporting the view that this receptor might mediate the capacity of inhaled anesthetics to produce immobility during noxious stimulation (i.e., would underlie MAC, the minimum alveolar concentration required to suppress movement in response to a noxious stimulus in 50% of subjects). In the present investigation in rats, we found that intrathecal administration of the 5HT-2A blocker, ketanserin, can decrease isoflurane MAC. This effect, presumably mediated by blockade of serotonin transmission in the spinal cord, reaches a maximum of 20%–25%. An additional decrease (to 60%) may be obtained by IV infusion of ketanserin, and presumably this decrease results from ketanserin’s actions on supraspinal centers. The IV doses of ketanserin that decreased MAC were approximately 100 µg · kg^-1 · min^-1 in rats, compared with usual clinical doses of 1.25 µg · kg^-1 · min^-1 in humans. These results indicate that 5HT2A receptors are in the neural circuitry influencing isoflurane MAC. These results, together with the blocking action of isoflurane on expressed 5HT2A receptors, strengthen the case for a role for 5HT2A receptors to isoflurane-induced immobility. However, because MAC for isoflurane is predominantly determined in the spinal cord, this result is consistent at most with a minor contribution of these receptors to the immobilizing action of isoflurane.

IMPLICATIONS: A subset of serotonin receptors, 5HT2A receptors, may mediate or modulate a minor portion of the immobility produced by inhaled anesthetics.

This article has been cited by other articles:

				S. T. Vermeire, K. R. Audenaert, A. A. Dobbeleir, R. H. De Meester, F. J. De Vos, and K. Y. Peremans Evaluation of the Brain 5-HT2A Receptor Binding Index in Dogs with Anxiety Disorders, Measured with 123I-5I-R91150 and SPECT J. Nucl. Med., February 1, 2009; 50(2): 284 - 289. [Abstract] [Full Text] [PDF]

				E. I. Eger II, D. E. Raines, S. L. Shafer, H. C. Hemmings Jr, and J. M. Sonner Is a New Paradigm Needed to Explain How Inhaled Anesthetics Produce Immobility? Anesth. Analg., September 1, 2008; 107(3): 832 - 848. [Abstract] [Full Text] [PDF]

				J. G. Bovill Anesthetic Pharmacology: Reflections of a Section Editor Anesth. Analg., November 1, 2007; 105(5): 1186 - 1190. [Full Text] [PDF]

				K. Mukaida, T. Shichino, S. Koyanagi, S. Himukashi, and K. Fukuda Activity of the Serotonergic System During Isoflurane Anesthesia Anesth. Analg., April 1, 2007; 104(4): 836 - 839. [Abstract] [Full Text] [PDF]

				R. A. Whittington and L. Virag Isoflurane decreases extracellular serotonin in the mouse hippocampus. Anesth. Analg., July 1, 2006; 103(1): 92 - 98. [Abstract] [Full Text] [PDF]